AVAILABLE MEDICINE FOR Buprenorphine Transdermal Patch
There are no products to list.
Buprenorphine is a partial opioid agonist used in transdermal patches to treat moderate to severe chronic pain. It provides pain relief with a lower risk of addiction and breathing problems compared to full opioid agonists, making it a good choice for long-term pain management. The patch attaches to opioid receptors in the brain to reduce pain. Its design allows for a steady release of medication over several days, ensuring consistent pain relief. This controlled release helps prevent the highs and lows often seen with oral or intravenous opioids, lowering the chance of misuse.
Common side effects of buprenorphine patches include constipation, dizziness, headaches, and dry mouth. More serious risks include breathing problems, especially for those with existing respiratory issues, as well as the potential for misuse and addiction. Approved by the FDA in 2010, buprenorphine patches provide a safer and more controlled way to manage chronic pain compared to traditional opioid treatments.
